- Home
- GNLN vs XXII Comparison
GNLN vs XXII Comparison
Compare GNLN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLN | XXII |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 7.8M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNLN | XXII |
|---|---|---|
| Price | $3.08 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 80.0K | ★ 187.9K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,653,000.00 | ★ $20,346,000.00 |
| Revenue This Year | $1,541.21 | N/A |
| Revenue Next Year | N/A | $136.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.98 |
| 52 Week Low | $2.68 | $0.78 |
| 52 Week High | $1,387.54 | $287.27 |
Technical Indicators
Market Signals| Indicator | GNLN | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 44.96 |
| Support Level | $2.91 | $1.06 |
| Resistance Level | $3.33 | $1.17 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 31.25 | 67.12 |
Price Performance
Historical ComparisonAbout GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.